Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation

Neurology

Volumn 77, Issue 15, 2011, Pages 1427-1431

  Fujita, Y ^a,d   Ikeda, M ^a   Yanagisawa, T ^b   Senoo, Y ^c   Okamoto, O ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Fujioka General Hospital   (Japan)

^c Isesaki Fukushima Hospital   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

A315E PROTEIN; PEPTIDES AND PROTEINS; TAR DNA BINDING PROTEIN; TARDBP PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; ARTICLE; CELL LOSS; CLINICAL FEATURE; CYTOPLASM; GENE MUTATION; MOTONEURON; NERVE CELL; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PARKINSONISM; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPINOCEREBELLAR TRACT;

EID: 82955235712     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318232ab87     Document Type: Article

References (24)

1. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362: 59-62. (Pubitemid 23087289)
2. Kabashi E, Valdmanis PN, Dion P, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008;40:572-574. (Pubitemid 351601218)
3. Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-1672. (Pubitemid 351432505)
4. Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008; 63:538-542. (Pubitemid 351614721)
5. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008;7:409-416.
6. Tamaoka A, Arai M, Itokawa M, et al. TDP-43 M337V mutation in familial amyotrophic lateral sclerosis in Japan. Intern Med 2010;49:331-334.
7. Pamphlett R, Luquin N, McLean C, Jew SK, Adams L. TDP-43 neuropathology is similar in sporadic amyotrophic lateral sclerosis with or without TDP-43 mutations. Neuropathol Appl Neurobiol 2009;35:222-225.
8. Cairns NJ, Perrin RJ, Schmidt RE, et al. TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report. Neuropathol Appl Neurobiol 2010;36:673-679.
9. Kadokura A, Yamazaki T, Kaunda S, et al. Phosphorylationdependent TDP-43 antibody detects intraneuronal dotlike structures showing morphological characters of granulovacuolar degeneration. Neurosci Lett 2009;463: 87-92.
10. Fujita Y, Omaha E, Takatama M, Al-Sarraj S, Okamoto K. Golgi apparatus of nigral neurons with α-synucleinpositive inclusions in patients with Parkinson's disease. Acta Neuropathol 2006;112:261-265. (Pubitemid 44275881)
11. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Tredici KD. Staining of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404. (Pubitemid 44469160)
12. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Viol 1995;69: 3584-3596.
13. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, Baralle FE. TDP-43 binds heterogenous nuclear ribonucleoprotein A/B through its C-terminal tail. J Biol Chem 2005;280:37572-37584.
14. Wang IF, Reddy NM, Shen CKJ. Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci USA 2002;99:13583-13588. (Pubitemid 35215425)
15. Arai A, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-611. (Pubitemid 44708852)
16. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133. (Pubitemid 44547757)
17. Gitcho MA, Baloh RH, Chakraverty S, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008;63:535-538. (Pubitemid 351614720)
18. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motoneuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motoneuron Disord 2000;1:293-299.
19. McCluskey LF, Elman LB, Martinez-Lage M, et al. Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology. Arch Neurol 2009;66:121-124.
20. Suzuki M, Irie T, Watanabe T, et al. Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study. J Neurol Sci 2008;268:140-144.
21. Takahashi H, Makifuchi T, Nakano R, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol 1994;88: 185-188. (Pubitemid 24233251)
22. Ince PG, Shaw JY, Jones C, Hudgson P. Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol 1996;92: 395-403. (Pubitemid 26317107)
23. Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K, Ohama E. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase I gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol 1996;55:1089-1101. (Pubitemid 26338021)
24. Ince PG, Tomkins J, Slade JY, Thatcher NM, Shaw PJ. Amyotrophic lateral sclerosis associated with genetic abnormalities in gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropathol Exp Neurol 1998;57:895-904. (Pubitemid 28478000)